Skip to main content

Dietary intakes of total polyphenol and its subclasses in association with the incidence of chronic kidney diseases: a prospective population‐based cohort study



As chronic kidney disease (CKD) is amongst the current global health challenges, this study is aiming to evaluate the long-term intake of total polyphenol and its subclasses in association with CKD incidence.


For the purpose of this study, a sample of 3021 Iranian adults (47 % men, aged 20–79 years) with no CKD diagnosis at baseline, were selected from the Tehran Lipid and Glucose Study population. The total intake of polyphenol and its major subclasses were assessed by a validated food frequency questionnaire and categorized as flavonoids, phenolic acids, stilbenes, and lignans. Although the morphological abnormalities of the kidneys or 3-month persistent urinalysis can distinctively define CKD, the glomerular filtration rate (eGFR) reduction is accepted as a more precise index of renal function. Therefore, eGFR < 60 mL/min/1.73m2 was the exclusive index of CKD diagnosis in the current study. The eGFR was calculated by the Modification of Diet in Renal Disease Study equation. Cox-regression analysis was used to assess the hazard ratio and 95 % confidence intervals of CKD in quartiles of the total polyphenols.


In this study, 355 CKD cases over 11,058.464 person-years was reported. The median (IQR) age of participants was 36 years (27–46) at baseline. Moderate intake of lignans (≤ 6.8 mg) was negatively associated with the incidence of CKD in the adjusted model. No significant associations were detected between higher amounts of lignin and total polyphenols (HR: 0.97, 95 % CI 0.67–1.40) and CKD incidence.


Based on the current findings, moderate intake of lignin possess CKD-protective properties by approximately 32 %. No independent associations were observed between higher amounts of lignins and CKD incidence.

Peer Review reports


Chronic kidney disease (CKD) is a public health challenge worldwide. It is commonly manifested by the loss of function or structural damage to the kidneys [1, 2]. Obesity, diabetes, hypertension and increased levels of inflammation and oxidative stress are the common risk factors of cardiovascular disease (CVD) and CKD [1, 3]. As habitual dietary intake is an effective modifiable factor in the CKD etiology, adopting a healthy lifestyle can prevent the incidence of CKD [4].

Adherence to specific dietary patterns including the Mediterranean diet [5] and the Dietary Approaches to Stop Hypertension (DASH) [6, 7] can positively contribute to the renal function. Alternatively, plant-based diets with higher constitution of fruits, vegetables, nuts, spices, herbs, cereals, legume, seeds, chocolate, and tea can prevent the occurrence of chronic conditions [8]. Plant-based food items are enriched with a diverse content of phytochemicals [9]. Polyphenols are the major micronutrients constituent of human diet, which are involved in many antioxidant and biological activities and affect various chronic disorders [10, 11]. Flavonoids, phenolic acids, stilbenes, and lignans are the four major subclasses of polyphenols [8]. Several studies have previously investigated the effect of polyphenol-rich red grape juice [12], green tee, coca [13] and white wine [14] in patients with renal failure. However, the CKD-preventive property of polyphenols in a regular diet is yet a matter of ongoing debate. Given the lack of adequate data on adults, this study aimed to investigate the association between long-term consumption of total polyphenol and its subclasses, including flavonoids, phenolic acids, stilbenes, and lignans with the incidence of CKD.


Study population

This longitudinal study was performed within the framework of the Tehran Lipid and Glucose Study (TLGS). This prospective study was launched in 1999 in five phases and primarily aimed to address and prevent the non-communicable diseases’ (NCDs) risk factors [15]. In spite of the first phase with a cross-sectional design, the four subsequent phases (II: 2002–2005, III: 2006–2008, IV: 2009–2011 and V: 2012–2015) were performed as prospective follow-up surveys.

The current study, a representative sample of 3021 individuals from phase III with 20–79 years of age and complete data, were recruited and followed-up. Pregnancy and lactation, energy consumption (800 > x > 4200 kcal/d), specific dietary patterns and any history of myocardial infarction, cerebral vascular accident or cancer at baseline was considered as the exclusion criteria. Ultimately, 2054 individuals were enrolled for the final follow-up analysis of 5.4 years.

All participants were initially asked to provide written informed consent.The study protocol was also approved by the ethics committee research council of the Research Institute for Endocrine Science (RIES), Shahid Beheshti University of Medical Science, Tehran, Iran.

Dietary assessment

The habitual dietary intake was evaluated by a valid and reliable semi-quantitative food-frequency questionnaire (FFQ) at baseline [16, 17]. The individual consumption frequency of each food item was designated by trained and experienced dietitians on daily, weekly or monthly basis. The portion sizes were collected in household measures and converted to grams. The USDA Food Composition Table (FCT) was used to calculate and interpret the energy and nutrient content of each food item. The estimated intake of total polyphenol and subclasses was based on the Phenol-Explorer database ( [18].

Measurement of covariates

The physical activity level of each participant was assessed by the Modifiable Activity Questionnaire which has previously been validated for the Iranian population [19]. A metabolic equivalent (MET-h/week) was calculated according to a list of common and daily routine activities.

Weight and height were collected to the nearest 0.1 kg and 0.1 cm, respectively. The weight was recorded in light clothing via a SECA digital weighing scale (Seca 707; Seca Corporation; range 0·1–150 kg), and height was taken without shoes on. BMI was defined as weight (kg) divided by square of height (m2). Arterial blood pressure was measured manually, using a mercury sphygmomanometer with a suitable cuff size for each participant after a 15-min rest.

Systolic (SBP) and Diastolic blood pressures were included the initial tapping and disappearance of Korotkoff sound, respectively. Blood pressure was measured twice and the average was considered as participant’s final measurement. Blood samples were taken from all participants at the TLGS research laboratory after a 12–14 h fasting.

Fasting plasma glucose (FPG) and 2-h plasma glucose (equivalent to 75 g anhydrous glucose; Cerestar EP) were measured by enzymatic colorimetric using glucose oxidase and with inter-and intra-assay CV < 2 %. Serum creatinine was measured by the standard colorimetric Jaffe_Kinetic reaction at baseline (2006–2008) and after 6 years of follow-up (2012–2015). Both Intra- and inter-assay CVs were below 3.1 %. All analyses were performed using commercial kits (Pars Azmoon Inc.).


Although the morphological abnormalities of the kidneys or 3-month persistent urinalysis can distinctively define CKD, the glomerular filtration rate (eGFR) reduction is accepted as a more precise index of renal function. Therefore, in this study, the eGFR was expressed as ml/min/1.73m2 of body surface area, using the Modification of Diet in Renal Disease (MDRD) equation [20] as follows.

$$ \mathrm{eGFR}=186\times {\left(\mathrm{Serum}\ \mathrm{creatinine}\right)}^{-1.154}\times {\left(\mathrm{Age}\right)}^{-0.203}\times \left(0.742\ \mathrm{if}\ \mathrm{female}\right)\times \left(1.210\ \mathrm{if}\ \mathrm{African}-\mathrm{American}\right) $$

Patients were classified based on the eGFR levels pertain to the National Kidney Foundation Guidelines [2]. In this regard, eGFR ≥ 60 ml/min/1.73m2 was considered as non-CKD and eGFR < 60 ml/min/1.73m2 represented CKD diagnosis. Hypertension was primarily defined as SBP/DBP ≥ 140/90 mm-Hg or current therapy for a definite diagnosis of hypertension [21]. Diabetes was also defined in accordance with the criteria of the American Diabetes Association (ADA) as fasting plasma glucose ≥ 126 mg/dl, 2-h post 75-g glucose load ≥ 200 mg/dl or current therapy for a definite diagnosis of diabetes [22].

Statistical analysis

In this study, the normal distribution of the variables was assessed by Kolmogorov–Smirnov test and Histogram chart. The participants’ characteristics and nutritional status across quartiles of total polyphenols were represented by mean ± SD and median [IQR] for normal and skewed distribution. Categorical variables were also reported by percentage. Linear regression model and Chi-square test were used for the trend of continuous and categorical variables in association with total polyphenol quartiles, respectively. Hazard ratio (HR) and 95 % confidence intervals (CI) of CKD incidence across the quartiles of total polyphenols were assessed by Cox regression analysis and the lowest quartile was considered as reference. Three models were specified for the analyses. The first model remained unadjusted for the variables. The second and third models were adjusted for sex, age, physical activity, total calorie intake, BMI, diabetes and hypertension. The proportionality assumption underlying the Cox model was examined, and no evidence of violation was observed. All analyses were performed via IBM SPSS version 16 (SPSS, Chicago, IL, USA) and P < 0.05 was considered significant (two-tailed).


In this study, the median (IQR) age of participants was 36 years (27–46) and men had a contribution of 47 % to the total study population. Within 11058.464 person-years of follow-up, 355 new cases of CKD were documented. Baseline characteristics and nutritional status of the participants across quartiles of total polyphenols are illustrated in Table 1. The data highlights the increasing trends of age (P for trend = 0.015), BMI (P for trend = 0.001), energy (P for trend < 0.001), and fat (P for trend = 0.003) across quartiles of total polyphenols, and the contradicting scenario for carbohydrates (P for trend < 0.001).

Table 1 Baseline characteristics and nutritional status of participants across quartiles of total polyphenols

The HRs for total polyphenol and its subclasses are described in Table 2. There were no significant associations between the total polyphenols and the incidence of CKD (HR: 0.97, 95 % CI 0.67–1.40). Furthermore, the CKD incidence was less significant among participants in the fourth quartile of flavonoids and phenolic acids comparing to the first quartile (HR: 1.07, 95 % CI 0.74–1.55 and HR: 1.14, 95 % CI 0.79–1.64, respectively). Across the subclasses of polyphenols, lignans had significant association with CKD incidence in the multivariable-adjusted model, with 34 % and 31 % reduced risk of CKD in the second and third quartiles comparing to the reference, respectively. Also, the association between total dietary polyphenols and the incidence of CKD in the first and fourth quartiles were insignificant. Compared with the first quartile of stilbenes, the HR of the last unadjusted model was 0.64 (95 % CI 0.48–0.87), which had a significant inverse trend that disappeared after adjusting for potential confounders.

Table 2 Multivariable-adjusted COX regression (95 % CIs) for incidence of chronic kidney disease according to quartiles of the total polyphenols and its subgroups

Further adjustment for fat, carbohydrate, whole grains, vegetables, fruits, and nuts did not have a substantial impact on the association between total polyphenol and its subclasses with CKD incidence.


This study investigated the association between total dietary polyphenol and its major subclasses with CKD incidence among adults in Tehran, Iran. In this regard, high intake of lignans was negatively associated with CKD incidence independent of the potential cofounders. However, no similar associations were depicted with higher values than 6.8 mg. CKD incidence had a 36 % decrease in the highest quartile of stilbenes comparing to the lowest quartile of the unadjusted model. Also, total polyphenols and the incidence of CKD did not have any significant associations. No significant associations were reported after adjusting for the confounding factors, which can be explained by the considerable effect of potential confounders.

To the best of our knowledge, this is the first study that concentrated on the association between the long-term intake of total polyphenol and its major subclasses with the CKD incidence. Results of this study confirm the CKD- protective properties of lignan at a moderate amount (≤ 6.8 mg), which can be attributed to the high content of antioxidants. It is suggested that increased antioxidant defenses and subsequently, reduced levels of oxidative stress may reduce the CVD risk factors [23]. In this context, some epidemiological studies have emphasized that CVD and CKD share some common risk factors including low serum HDL cholesterol, hypertension, hypertriglyceridemia, and hyperglycemia [21, 24]. Although the CVD risk factors tend to increase progressively as a result of renal function reduction, the proper management of the cardiovascular system, could decrease the risk of CVD and CKD manifestations [21, 24].

The existing data on the consumption of lignan remains inconsistent [25, 26]. While a moderate intake of lignin promotes beneficial health effects, excessive amounts could act as estrogen antagonists [27] or enzyme inhibitor in the metabolism of sex hormones such as 5-a-reductase and 17b-hydroxysteroid dehydrogenase [22]. In other words, higher intake of lignan may have null effects on CVD risk factors, for which two mechanisms have been proposed [22], including the increased CVD risk factors and decreased level of free estradiol and testosterone in women and men, respectively [22]. Therefore, it seems as only a moderate amount of lignan (≤ 6.8 mg) may appear effective with an approximate 32 % decrease in CVD risk factors, and subsequently, CKD.

Borges et al. has performed a study on diabetic nephropathy patients to approve the CKD-protective properties of green tee polyphenols [4]. It was suggested that decreasing albuminuria [4] and inhibition of the inflammatory mediators (such as TNF-a) may be the underlying mechanisms. This study has also indicated that total polyphenols were not associated with the lower risk of CKD [4]. Meanwhile, Cynthia et al. have reported contradicting findings that can be explained by the interaction of the multiple treatments received by the diabetic participants and the green tee polyphenols. In this sense, a meta-analysis endorsed the preliminary support of polyphenol-rich interventions in the improvement of CVD risk factors among hemodialysis patients [28]. Despite individual studies in support of significant improvements, pooled results were contradicting due to the exclusion of myeloperoxidase, diastolic blood pressure, and triglycerides from the outcomes [28]. Myeloperoxidase, as a measure of oxidative stress, was the only factor with a large pooled effect size [28]. Also, the individualized polyphenol metabolism as a result of individual gastrointestinal microbiome content, brought diversity to the range of responses among the population [28]. In this respect, no specific associations were observed in the mentioned study, which could conceal the beneficial effect of total polyphenol intake.

This study had potential limitations that must be considered, as well. Firstly, the total intake of polyphenols and its subclasses were estimated by the Phenol-Explorer database () due to the unavailability of the Iranian version. Secondly, while CKD can be defined as abnormalities in the renal structure or function that persist for more 3 months and possess health challenges, this study has merely considered eGFR reduction to address CKD. Thirdly, the albumin-to-creatinine ratio (ACR) was not assessed and a creatinine double-checking procedure did not take place, which may have affected the accuracy of the findings and the interpretations. Also, larger sample sizes may have yielded significant associations. Lastly, despite the adjustments for potential confounders, the impact of residual confounders could not be ruled out.


In conclusion, the result of this prospective study did not confirm any associations between total polyphenols and the incidence of CKD. However, it was finalized that lignan can only be CKD- protective by approximately 32 %, when consumed moderately (≤ 6.8 mg) and higher amounts of lignan possess no significant effects. Therefore, there is no doubt that further research is required to differentiate the impact of low, moderate and high amounts of lignan intake on CKD incidence.

Availability of data and materials

The datasets used and/or analyzed during the current study are available from the corresponding author on reasonable request.



Chronic Kidney Disease


Glomerular Filtration Rate


Tehran Lipid and Glucose Study


Dietary Approaches to Stop Hypertension


Food-Frequency Questionnaire


Food Composition Table


Modification of Diet in Renal Disease


Research Institute for Endocrine Sciences


Tumor necrosis factor-alpha


  1. 1.

    Levey AS, Coresh J. Chronic kidney disease. Lancet. 2012;379(9811):165–80.

    Article  Google Scholar 

  2. 2.

    National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis. 2002;39(2 Suppl 1):1–266.

  3. 3.

    Santoro A, Mancini E. Cardiac effects of chronic inflammation in dialysis patients. Nephrol Dial Transplant. 2002;17(Suppl 8):10–5.

    Article  Google Scholar 

  4. 4.

    Borges CM, Papadimitriou A, Duarte DA, Lopes de Faria JM, Lopes de Faria JB. The use of green tea polyphenols for treating residual albuminuria in diabetic nephropathy: A double-blind randomised clinical trial. Sci Rep. 2016;6:28282.

    CAS  Article  Google Scholar 

  5. 5.

    Asghari G, Farhadnejad H, Mirmiran P, Dizavi A, Yuzbashian E, Azizi F. Adherence to the Mediterranean diet is associated with reduced risk of incident chronic kidney diseases among Tehranian adults. Hyperten Res. 2017;40(1):96–102.

    Article  Google Scholar 

  6. 6.

    Asghari G, Yuzbashian E, Mirmiran P, Azizi F. The association between dietary approaches to stop hypertension and incidence of chronic kidney disease in adults: the Tehran lipid and glucose study. Nephrol Dial Transplant. 2017;32(suppl_2):ii224-30.

    CAS  Article  Google Scholar 

  7. 7.

    Yuzbashian E, Asghari G, Mirmiran P, Amouzegar-Bahambari P, Azizi F. Adherence to low-sodium dietary approaches to stop hypertension-style diet may decrease the risk of incident chronic kidney disease among high-risk patients: a secondary prevention in prospective cohort study. Nephrol Dial Transplant. 2018;33(7):1159–68.

    CAS  Article  Google Scholar 

  8. 8.

    Scalbert A, Morand C, Manach C, Remesy C. Absorption and metabolism of polyphenols in the gut and impact on health. Biomed Pharmacother. 2002;56(6):276–82.

    CAS  Article  Google Scholar 

  9. 9.

    Amiot MJ, Riva C, Vinet A. Effects of dietary polyphenols on metabolic syndrome features in humans: a systematic review. Obesity reviews: an official journal of the International Association for the Study of Obesity. 2016;17(7):573–86.

    CAS  Article  Google Scholar 

  10. 10.

    Kuhnau J. The flavonoids. A class of semi-essential food components: their role in human nutrition. World Rev Nutr Diet. 1976;24:117–91.

    CAS  Article  Google Scholar 

  11. 11.

    Scalbert A, Williamson G. Dietary intake and bioavailability of polyphenols. J Nutr. 2000;130(8S Suppl):2073S-85S.

    PubMed  Google Scholar 

  12. 12.

    Castilla P, Echarri R, Davalos A, Cerrato F, Ortega H, Teruel JL, et al. Concentrated red grape juice exerts antioxidant, hypolipidemic, and antiinflammatory effects in both hemodialysis patients and healthy subjects. Am J Clin Nutr. 2006;84(1):252–62.

    CAS  Article  Google Scholar 

  13. 13.

    Rassaf T, Rammos C, Hendgen-Cotta UB, Heiss C, Kleophas W, Dellanna F, et al. Vasculoprotective effects of dietary cocoa flavanols in patients on hemodialysis: a double-blind, randomized, placebo-controlled trial. Clin J Am Soc Nephrol. 2016;11(1):108–18.

    CAS  Article  Google Scholar 

  14. 14.

    Migliori M, Panichi V, de la Torre R, Fito M, Covas M, Bertelli A, et al. Anti-inflammatory effect of white wine in CKD patients and healthy volunteers. Blood Purific. 2015;39(1–3):218–23.

    CAS  Article  Google Scholar 

  15. 15.

    Azizi F, Ghanbarian A, Momenan AA, Hadaegh F, Mirmiran P, Hedayati M, et al. Prevention of non-communicable disease in a population in nutrition transition: Tehran lipid and glucose study phase II. Trials. 2009;10(1):5.

    Article  Google Scholar 

  16. 16.

    Mirmiran P, Esfahani FH, Mehrabi Y, Hedayati M, Azizi F. Reliability and relative validity of an FFQ for nutrients in the Tehran lipid and glucose study. Public Health Nutr. 2010;13(5):654–62.

    Article  Google Scholar 

  17. 17.

    Esfahani FH, Asghari G, Mirmiran P, Azizi F. Reproducibility and relative validity of food group intake in a food frequency questionnaire developed for the Tehran lipid and glucose study. J Epidemiol. 2010;20(2):150–8.

    Article  Google Scholar 

  18. 18.

    Perez-Jimenez J, Neveu V, Vos F, Scalbert A. Systematic analysis of the content of 502 polyphenols in 452 foods and beverages: an application of the phenol-explorer database. J Agric Food Chem. 2010;58(8):4959–69.

    CAS  Article  Google Scholar 

  19. 19.

    Momenan AA, Delshad M, Sarbazi N, Rezaei Ghaleh N, Ghanbarian A, Azizi F. Reliability and validity of the modifiable activity questionnaire (MAQ) in an Iranian urban adult population. Arch Iran Med. 2012;15(5):279–82.

    PubMed  Google Scholar 

  20. 20.

    Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of diet in renal disease study group. Ann Intern Med. 1999;130(6):461–70.

    CAS  Article  Google Scholar 

  21. 21.

    Eckardt KU, Coresh J, Devuyst O, Johnson RJ, Kottgen A, Levey AS, et al. Evolving importance of kidney disease: from subspecialty to global health burden. Lancet. 2013;382(9887):158–69.

    Article  Google Scholar 

  22. 22.

    Raffaelli B, Hoikkala A, Leppala E, Wahala K, Enterolignans. Analytical technologies in the biomedical life sciences. J Chromatogr B. 2002;777(1–2):29–43.

    CAS  Article  Google Scholar 

  23. 23.

    L.Gupta K, Sahni N. Dietary antioxidents and oxidative stress in predialysis chronic kidney disease patients. J Nephropathol. 2012;1(3):134–42.

    Article  Google Scholar 

  24. 24.

    Gansevoort RT, Correa-Rotter R, Hemmelgarn BR, Jafar TH, Heerspink HJ, Mann JF, et al. Chronic kidney disease and cardiovascular risk: epidemiology, mechanisms, and prevention. Lancet. 2013;382(9889):339–52.

    Article  Google Scholar 

  25. 25.

    Nurmi T, Mursu J, Penalvo JL, Poulsen HE, Voutilainen S. Dietary intake and urinary excretion of lignans in Finnish men. Br J Nutr. 2010;103(5):677–85.

    CAS  Article  Google Scholar 

  26. 26.

    Morisset AS, Lemieux S, Veilleux A, Bergeron J, John Weisnagel S, Tchernof A. Impact of a lignan-rich diet on adiposity and insulin sensitivity in post-menopausal women. Br J Nutr. 2009;102(2):195–200.

    CAS  Article  Google Scholar 

  27. 27.

    Landete J. Plant and mammalian lignans: a review of source, intake, metabolism, intestinal bacteria and health. Food Res Int. 2012;46(1):410–24.

    CAS  Article  Google Scholar 

  28. 28.

    Marx W, Kelly J, Marshall S, Nakos S, Campbell K, Itsiopoulos C. The effect of polyphenol-rich interventions on cardiovascular risk factors in haemodialysis: A systematic review and meta-analysis. Nutrients. 2017;9(12):1345.

    Article  Google Scholar 

Download references


We express our appreciation to Islamic Azad University, Science and Research Branch for their contribution to the study.


This work was funded by a grant from the RIES, Shahid Beheshti University of Medical Sciences, Tehran, Iran. The funding body played no role in the design of the study and collection, analysis, and interpretation of data and in writing the manuscript.

Author information




The authors hereby appreciate the great contributions of the study participants. Overall, P.M. supervised the project and approved the final version of the manuscript to be submitted; G.A. and P.R. designed the research; E.Y. and P.R. analyzed and interpreted the data; F.A. and G.A. critically reviewed the manuscript; G.A., E.Y., and P.R. drafted the initial manuscript. All authors read and approved the final manuscript.

Corresponding author

Correspondence to Golaleh Asghari.

Ethics declarations

Ethics approval and consent to participate

All participants were initially asked to provide written informed consent. The study protocol was also approved by the ethics committee research council of the Research Institute for Endocrine Science (RIES), Shahid Beheshti University of Medical Science, Tehran, Iran.

Consent for publication

Not applicable’ for that section.

Competing interests

The authors declare that they have no competing interests.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit The Creative Commons Public Domain Dedication waiver ( applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Mirmiran, P., Yuzbashian, E., Rahbarinejad, P. et al. Dietary intakes of total polyphenol and its subclasses in association with the incidence of chronic kidney diseases: a prospective population‐based cohort study. BMC Nephrol 22, 84 (2021).

Download citation


  • Polyphenols
  • Glomerular Filtration rate (GFR)
  • Chronic kidney disease (CKD)
  • Tehran lipid and glucose study (TLGS)